102 related articles for article (PubMed ID: 6574685)
1. Percutaneous estrogen therapy. Endometrial response and metabolic effects.
Holst J
Acta Obstet Gynecol Scand Suppl; 1983; 115():1-30. PubMed ID: 6574685
[TBL] [Abstract][Full Text] [Related]
2. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects.
Helgason S
Acta Obstet Gynecol Scand Suppl; 1982; 107():1-29. PubMed ID: 6282033
[TBL] [Abstract][Full Text] [Related]
3. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous estrogen replacement therapy. Effects on circulating estrogens, gonadotropins and prolactin.
Holst J; Cajander S; Carlström K; Damber MG; von Schoultz B
Acta Obstet Gynecol Scand; 1983; 62(1):49-53. PubMed ID: 6858624
[TBL] [Abstract][Full Text] [Related]
5. [Effect of a 17 beta estradiol gel preparation on hormone levels in menopausal women].
Araya V; Contreras P; Aguirre C; Foradori A
Rev Med Chil; 1995 Sep; 123(9):1116-21. PubMed ID: 8728735
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure and hemodynamics in postmenopausal women during estradiol-17 beta substitution.
Luotola H
Ann Clin Res; 1983; 15 Suppl 38():1-121. PubMed ID: 6367617
[TBL] [Abstract][Full Text] [Related]
7. Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium--a randomized controlled trial.
Valiati B; Capp E; Edelweiss MI; de Freitas FM; Wender MC
Maturitas; 2009 Jan; 62(1):81-4. PubMed ID: 19097715
[TBL] [Abstract][Full Text] [Related]
8. [The endometrium under the effects of hormone replacement therapy in menopause with percutaneous estradiol and low-dose micronized progesterone].
Philippe E; Faguer B; Engelman A; Charpin C; Loubière R; de Mascarel A; Leduc F; Dupin P; Hemet J; Vauzelle JL
Pathologica; 1993; 85(1099):475-87. PubMed ID: 8127629
[TBL] [Abstract][Full Text] [Related]
9. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration.
De Lignieres B; Basdevant A; Thomas G; Thalabard JC; Mercier-Bodard C; Conard J; Guyene TT; Mairon N; Corvol P; Guy-Grand B
J Clin Endocrinol Metab; 1986 Mar; 62(3):536-41. PubMed ID: 3080464
[TBL] [Abstract][Full Text] [Related]
10. [Percutaneous estrogen therapy in the post-menopausal period].
Keller PJ
Schweiz Med Wochenschr; 1989 Jul; 119(29):999-1004. PubMed ID: 2678438
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.
Sweeney AT; Tangpricha V; Weinberg J; Malabanan AO; Chimeh FN; Holick MF
Transl Res; 2006 Oct; 148(4):164-70. PubMed ID: 17002918
[TBL] [Abstract][Full Text] [Related]
12. A comparison of liver protein induction in postmenopausal women during oral and percutaneous oestrogen replacement therapy.
Holst J; Cajander S; Carlström K; Damber MG; von Schoultz B
Br J Obstet Gynaecol; 1983 Apr; 90(4):355-60. PubMed ID: 6682335
[TBL] [Abstract][Full Text] [Related]
13. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
[TBL] [Abstract][Full Text] [Related]
14. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
[TBL] [Abstract][Full Text] [Related]
15. Cellular morphometric analysis of the postmenopausal endometrium during treatment with percutaneous estradiol-17 beta with and without oral gestagen.
Holst J; Cajander S; von Schoultz B
Acta Obstet Gynecol Scand; 1983; 62(3):267-70. PubMed ID: 6624399
[TBL] [Abstract][Full Text] [Related]
16. [Percutaneous estrogen replacement therapy. An alternative for oral treatment].
Holst J; von Schoultz B
Duodecim; 1983; 99(20):1457-62. PubMed ID: 6653450
[No Abstract] [Full Text] [Related]
17. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
Johannisson E; Holinka CF; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
[TBL] [Abstract][Full Text] [Related]
18. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
[TBL] [Abstract][Full Text] [Related]
19. Effects of testosterone and estrogen treatment on the distribution of sex hormone receptors in the endometrium of postmenopausal women.
Zang H; Sahlin L; Masironi B; Hirschberg AL
Menopause; 2008; 15(2):233-9. PubMed ID: 18030175
[TBL] [Abstract][Full Text] [Related]
20. Endometrial safety with a low-dose intrauterine levonorgestrel-releasing system after 3 years of estrogen substitution therapy.
Wildemeersch D; Schacht E; Wildemeersch P; Calleweart K; Pylyser K; De Wever N
Maturitas; 2004 May; 48(1):65-70. PubMed ID: 15223110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
